Table 1

 Characteristics of patients on entry to trial

No treatment(n = 95)Ca(n = 85)Et(n = 81)Et+Ca(n = 88)Total(n = 349)
BMD, bone mineral density; Ca, calcium; Et, etidronate.
Stratum A (n)46424142171
Stratum B (n)38333333137
Stratum C (n)111071341
% male61.157.651.959.157.6
Weight (kg)
    Mean (SD)72.4 (12.8)72.4 (14.2)74.8 (15.0)76.3 (16.0)73.9 (14.5)
    N94827684336
Age (years)
    Mean (SD)60.2 (7.6)60.3 (6.0)59.5 (7.5)58.7 (7.7)59.7 (7.3)
    N94827685337
Activities
    Limited40354036151
    Normal48423141162
    Brisk655824
    Missing135312
Previously diagnosed osteoporotic fractures at entry (n)98101037
Semi-quantitative fractures evident on x ray at entry (n)24263125106
Either of above (n)27283429118 (34%)
Standardised BMD L2–L4 (mg/cm2)
    Mean (SD)1017 (196)987 (173)997 (152)954 (199)989 (182)
    N46433741167
Standardised BMD proximal femur (mg/cm2)
    Mean (SD)799 (150)795 (138)806 (118)794 (152)798 (140)
    N47423741167